GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Tobacco Products » 22nd Century Group Inc (NAS:XXII) » Definitions » ROE % Adjusted to Book Value

22nd Century Group (22nd Century Group) ROE % Adjusted to Book Value

: 0.00% (As of Dec. 2023)
View and export this data going back to 2011. Start your Free Trial

22nd Century Group's ROE % for the quarter that ended in Dec. 2023 was -4,357.88%. 22nd Century Group's PB Ratio for the quarter that ended in Dec. 2023 was N/A. 22nd Century Group's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was N/A.


22nd Century Group ROE % Adjusted to Book Value Historical Data

The historical data trend for 22nd Century Group's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

22nd Century Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -16.26 -5.35 -7.77 -35.83 -

22nd Century Group Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Adjusted to Book Value Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -47.02 -40.01 -84.71 -451.97 -

Competitive Comparison

For the Tobacco subindustry, 22nd Century Group's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


22nd Century Group ROE % Adjusted to Book Value Distribution

For the Tobacco Products industry and Consumer Defensive sector, 22nd Century Group's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where 22nd Century Group's ROE % Adjusted to Book Value falls into.



22nd Century Group ROE % Adjusted to Book Value Calculation

22nd Century Group's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-321.53% / N/A
=N/A

22nd Century Group's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-4,357.88% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


22nd Century Group ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of 22nd Century Group's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


22nd Century Group (22nd Century Group) Business Description

Traded in Other Exchanges
N/A
Address
500 Seneca Street, Suite 507, Buffalo, NY, USA, 14204
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has two operating segments; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain 95% less nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM, and The hemp/cannabis segment is engaged in providing hemp-derived cannabinoid ingredients and API, as well as a CDMO to the consumer goods industry. It derives a majority of its revenue from the tobacco segment.
Executives
Andrew Arno director C/O MERRIMAN CURHAN FORD GROUP, INC., 600 CALIFORNIA STREET, 9TH FLOOR, SAN FRANCISCO CA 94108
James A Mish director, officer: Chief Executive Officer 8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221
John Franzino officer: Chief Administrative Officer 8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221
Peter Ferola officer: Chief Legal Officer BIOTELEMETRY, INC., 1000 CEDAR HOLLOW ROAD, #102, MALVERN PA 19355
John J Miller officer: President, Tobacco 500 SENECA STREET, SUITE 507, BUFFALO NY 14204
Lucille S Salhany director C/O HEWLETT-PACKARD CO, 3000 HANOVER STREET, PALO ALTO CA 94304
Michael Zercher officer: Chief Operating Officer 8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221
Robert Hugh Kinsman officer: Chief Financial Officer 500 SENECA STREET, SUITE 507, BUFFALO NY 14204
Clifford B Fleet director 6601 WEST BROAD STREET, RICHMOND VA 23230
Richard F Fitzgerald officer: Chief Financial Officer C/O TECHPRECISION CORPORATION, ONE BELLA DRIVE, WESTMINSTER MA 01473
Anthony L. Johnson director C/O 22ND CENTURY GROUP, INC., 500 SENECA STREET, SUITE 507, BUFFALO NY 14204
Richard M. Sanders director 1119 PIEDRA RONDO, SANTA FE NM 87501
Roger D O'brien director C/O 22ND CENTURY GROUP, INC., 8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221
Michael Koganov director 8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221
Nora B Sullivan director C/O RAND CAPITAL CORP, 2200 RAND BLDG, BUFFALO NY 14203